These fruits may hold key to beating obesity, diabetes, heart disease

Credit: Unsplash+

Researchers at Western University have made an intriguing discovery about a compound found in sweet oranges and tangerines. This compound, known as nobiletin, might be a key player in the fight against obesity, diabetes, and heart disease.

In their experiments, the scientists fed mice a diet high in fat and cholesterol. Some of these mice were also given nobiletin. The results were striking.

The mice that received nobiletin were significantly leaner than those that didn’t. They also showed lower levels of insulin resistance and blood fats, which are common problems associated with obesity.

But the researchers didn’t stop there. They also looked at mice that were already obese and suffering from related health issues.

Remarkably, nobiletin was not only able to stop the progression of these problems but even reverse some of them. This included reducing the build-up of plaque in the arteries, a condition known as atherosclerosis, which is a major risk factor for heart disease.

One of the most interesting findings of the study was how nobiletin works. The scientists initially thought it might be affecting a pathway in the body known as AMP Kinase.

This pathway is crucial for managing how the body uses fat, turning on the mechanisms that burn fat for energy and blocking fat production.

However, their results showed that nobiletin doesn’t act on this pathway at all. Instead, it seems to bypass this major regulator, suggesting it has a unique way of affecting the body’s fat metabolism.

This discovery is particularly important because it implies that nobiletin won’t interfere with medications that target the AMP Kinase system.

Many drugs used to treat metabolic diseases act on this pathway, so finding a treatment that works independently of it could be highly beneficial.

The next steps for the research team are crucial. They plan to test nobiletin in human trials to see if it has the same beneficial effects on metabolism.

If these trials are successful, nobiletin could become a powerful tool in preventing and treating obesity and its associated diseases.

This study, led by Murray Huff and published in the Journal of Lipid Research, opens up exciting possibilities for new treatments. It’s a promising development for millions of people worldwide who struggle with obesity and its complications.

With further research, compounds like nobiletin could offer a natural and effective way to improve health outcomes.

If you care about nutrition, please read studies about berry that can prevent cancer, diabetes, and obesity, and the harm of vitamin D deficiency you need to know.

For more information about nutrition, please see recent studies about the connection between potatoes and high blood pressure,  and results showing why turmeric is a health game-changer.

Copyright © 2024 Knowridge Science Report. All rights reserved.